"Study Finds Health Risks For Transgender Women On Hormone Therapy" - Avichai Scher
Transgender women on hormone therapy may be at a higher risk for cardiovascular problems, such as stroke, blood clots and heart attack, researchers reported Monday. Joshua Safer, MD, executive director of the Center for Transgender Medicine and Surgery at Mount Sinai, said that while the cardiovascular risk is higher for transgender women, it’s not that high. There were 148 cardiovascular events recorded out of the 2,842 transgender women in the eight-year period. “The confirmation of this risk is good to have, so patients can be warned and precautions can be taken. But I think most transgender women would conclude the risk is not high enough to forgo hormone therapy.”
- Joshua Safer, MD, Executive Director of The Center for Transgender Medicine and Surgery at Mount Sinai, Senior Faculty, Endocrinology, Icahn School of Medicine at Mount Sinai
Additional coverage:
Caring for Transgender Persons: What Clinicians Should Know
Dec 19, 2019 View All Press Releases"Anatomy Does Not Determine Gender, Experts Say" -Denise Grady
Oct 23, 2018 View All Press Releases